Experimental frontiers for clinical applications: Novel approaches to understanding mechanisms of lymph Node metastases in melanoma
- 1 June 2006
- journal article
- retracted article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 25 (2) , 257-267
Abstract
Sentinel lymph nodes are the first nodes to receive lymph from primary tumors and are the preferential site of initial metastases. Sentinel nodes show morphology changes that suggests immune modulation with reduced antigen-presenting dendritic cells, activated T lymphocytes, high endothelial venules and transvenular migration of T lymphocytes. Tumor cells generate down-regulatory molecules. We postulate that tumor-induced immune dysfunction facilitates establishment of nodal metastases. Nodal immune modulation can be reversed by granulocyte macrophage colony-stimulating factor (GMCSF), a finding with implications for future therapy to prevent or reverse these nodal metastases.Keywords
This publication has 85 references indexed in Scilit:
- Matched Skin and Sentinel Lymph Node Samples of Melanoma Patients Reveal Exclusive Migration of Mature Dendritic CellsThe American Journal of Pathology, 2005
- The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanomaBritish Journal of Dermatology, 2004
- Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSFEuropean Journal of Cancer, 2003
- Does the Tumor Status of the Regional Lymph Nodes Really Matter in Melanoma?Annals of Surgical Oncology, 2001
- Sentinel Lymph Nodes Show Profound Downregulation of Antigen-Presenting Cells of the Paracortex: Implications for Tumor Biology and TreatmentLaboratory Investigation, 2001
- Selective Modulation of Paracortical Dendritic Cells and T-Lymphocytes in Breast Cancer Sentinel Lymph NodesThe Breast Journal, 2000
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992
- Lymphatic Drainage of Skin to a Sentinel Lymph Node in a Feline ModelAnnals of Surgery, 1991
- Variations in lymphokine generation by individual lymph nodes draining human malignant tumorsCancer Immunology, Immunotherapy, 1989
- Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2Cellular Immunology, 1988